Dollar Tree (DLTR) came out with quarterly earnings of $2.11 per share, missing the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $2.55 per share a year ago.

Online pet products retailer Chewy (CHWY -1.41%) reported fiscal 2024 fourth-quarter earnings on Wednesday, March 26, that topped analysts' consensus expectations. Revenue for the quarter surged 14.9% year over year to $3.25 billion, outperforming forecasts of $3.2 billion.

LOWELL, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, today announced the availability of a new MACOM PURE DRIVE™ EML laser driver with equalizer targeting low power linear SFP112 modules for next- generation 50G and 100G Fronthaul applications.

Not for distribution to U.S. news wire services or dissemination in the United States. This news release constitutes a "designated news release" for the purposes of the Corporation's prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024.

Many space-oriented stocks went public by merging with special purpose acquisition companies (SPACs) over the past few years. However, most of those stocks crumbled as rising interest rates drove investors toward more conservative sectors.

LOS ANGELES , March 26, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against e.l.f. Beauty, Inc. ("e.l.f.

LOS ANGELES , March 26, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skyworks Solutions, Inc. ("Skyworks" or "the Company") (NASDAQ: SWKS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 30, 2024 and February 5, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before May 5, 2025.

Amazon (AMZN) is testing a new artificial intelligence (AI) shopping tool that finds new products matching a consumer's interests and is also reportedly testing a health-focused chatbot.

After a rough patch, it seems the biotech industry may be staging a comeback. Several biotech firms have gone public this year, and those focused on obesity treatments, gene therapies, and more have high expectations.

CDNS' robust portfolio amid increasing design activity is promising, but external risks warrant caution. Investors should wait for a better entry point.

Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced first dosing in an investigational new drug (IND)-enabling GLP (Good Laboratory Practice)-compliant toxicology and toxicokinetics study of its lead asset, SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD). “This IND-enabling safety study and our concurrent GLP-compliant pharmacokinetic and pharmacodynamic study, if successful, will provide the last preclinical data needed to open an IND for SPC-15,” said Eric …

I am upgrading my recommendation on Sabesp shares from hold to buy due to strong 4Q24 results, showing revenue and profit growth. Despite a lower EBIT due to redundancy provisions, Sabesp's operational efficiency post-privatization and healthy leverage position support a positive outlook. SBS stock is undervalued, trading at 5.4x EV/EBITDA versus a 5-year average of 6.56x, indicating a potential 21% upside.

Stocks like BWXT Technologies, GE Vernova and Constellation Energy offer a great opportunity for investors who want to create a nuclear energy portfolio.

Following reports that Pres. Trump may target import tariffs on Copper (/HG), Kevin Green dives into how that impacts the U.S. economy.

BRP Inc. (DOOO) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $1.81 per share a year ago.

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC's 74th Annual Scientific Session & Expo.

DURHAM, N.C., March 26, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) ("374Water") (the "Company"), a global leader in waste destruction technology for the municipal, federal, and industrial markets, today announced that it will participate in the Gabelli Funds' 11th Annual Waste, Recycling & Environmental Services Symposium taking Place Thursday, April 3rd, 2025, at The Harvard Club, New York City.

Graphic Packaging's strategic divestiture of the Augusta facility and investment in the Waco facility aims to optimize capital allocation and enhance long-term profitability. Despite a challenging 2024, the company managed volume pressures and protected margins, with a stable outlook for 2025 driven by innovation and productivity gains. Trading at a discount to peers, Graphic Packaging presents an attractive entry point, with significant upside potential as the Waco facility comes online in late 2025.

Conversion of Existing $2.5 Million in Debt to Equity and Additional Financing Commitments of $1.65 Million Strengthens Balance Sheet and Lowers Near-Term Cash Needs BUENA PARK, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Yoshiharu Global Co. (NASDAQ: YOSH) ("Yoshiharu" or the "Company"), a restaurant operator specializing in authentic Japanese ramen & rolls, today announced that it entered into additional financing commitments with certain investors for $1.65 million and, as a result of such financing transactions, as of the date hereof, the Company believes that it has regained compliance with the stockholders' equity requirement for continued listing on Nasdaq.

More than three decades have passed since the first ETFs hit the investment landscape. Factor ETFs have long played a key role in helping investors construct portfolios, but are we entering a factor 2.